Elsubrutinib (ABBV-105) is a potent, selective, and irreversible Brutons tyrosine kinase (BTK) inhibitor with an IC50 of 0.18 µM. This orally bioavailable small molecule is a valuable tool for investigating BTKs role in inflammatory and autoimmune disease pathways in both cellular and animal models.
Molekulargewicht:
297.36
Reinheit:
99.77% (May vary between batches)
CAS Nummer:
[1643570-24-4]
Formel:
C17H19N3O2
Target-Kategorie:
BTK
Anwendungsbeschreibung:
Solubility: DMSO:80.00 mg/mL (269.03 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten